Main > ONCOLOGY (**) > CholangioCarcinoma>MET>FGFR2+> > TREAT.: > CH. H. FGFR Small Inhibitor CAPs

---

CH. H. FGFR Small Inhibitor CAPs's subsections
(*) CA Approval Date: 2021. 09.29
(*) USA Approval Date: 2021. 05.28
Biliary Tract Cancer
Company
FGFR: fibroblast growth factor rece
Generic Name: Infigratinib
Marketing CA By:
Marketing USA By
RTM
RTM Web-Site
WIPO Patent Number:

CH. H. FGFR Small Inhibitor CAPs's products
This section has no products